In vivo anti-tumor results showed that the tumor inhibition rate of [PHC]PP@ HA NPs, which provided Hb for oxygen on demand, reached nearly 100%, significantly outperforming PTT alone or Hb-free nanoparticles ([PC]PP@ HA NPs). This evidence concerns the gene GSTM1 and neoplasm.